Skip to main content
. 2021 Feb 2;15(1):79–89. doi: 10.1049/nbt2.12009

FIGURE 1.

FIGURE 1

Powder X‐ray diffraction (PXRD) patterns of the Gr (a), graphene oxide (GO) (b), ellagic acid (ELA)‐graphene oxide (GO) nanocomposite (c) and ELA drug (d)